Login:
Share:
Email Facebook Twitter

Ark Therapeutics Regulatory News (AKT)



Regulatory News for Ark Therapeutics (AKT)


Share Price: 0.435Bid: 0.40Ask: 0.47Change: 0.00 (0.00%)No Movement on Ark Ther Grp
Spread: 0.07Spread as %: 17.50%Open: 0.435High: 0.44Low: 0.415Yesterday’s Close: 0.435





Blocklisting Interim Review

Wed, 6th Jun 2012 14:41

RNS Number : 8166E
Ark Therapeutics Group PLC
06 June 2012
 

?

Ark Therapeutics Group plc

6 June 2012

 

BLOCKLISTING SIX MONTHLY RETURN

 

1.         Name of applicant

Ark Therapeutics Group plc

 

2.         Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme

 

3.         Period of return

From 03/12/2011 - 02/06/2012

 

4.         Balance of unallotted securities under scheme from previous return

2,271,252

 

5.         Plus:  The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6.         Less: Number of securities issued/allotted under the scheme during period

Nil

 

7.         Equals: Balance under the scheme not yet issued/allotted at end of period

2,271,252

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1.         Name of applicant

Ark Therapeutics Group plc

 

2.         Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

 

3.         Period of return

From 03/12/2011 - 02/06/2012

 

4.         Balance of unallotted securities under scheme from previous return

939,433

 

5.         Plus:  The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6.         Less: Number of securities issued/allotted under the scheme during period

Nil

 

7.         Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1.         Name of applicant

Ark Therapeutics Group plc

 

2.         Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

 

3.         Period of return

From 03/12/2011 - 02/06/2012

 

4.         Balance of unallotted securities under scheme from previous return

683,200

 

5.         Plus:  The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6.         Less: Number of securities issued/allotted under the scheme during period

Nil

 

7.         Equals: Balance under the scheme not yet issued/allotted at end of period

683,200

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1.         Name of applicant

Ark Therapeutics Group plc

 

2.         Name of scheme

Ark Therapeutics Group Approved Share Option Plan

 

3.         Period of return

From 03/12/2011 - 02/06/2012

 

4.         Balance of unallotted securities under scheme from previous return

1,000,000

 

5.         Plus:  The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6.         Less: Number of securities issued/allotted under the scheme during period

Nil

 

7.         Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

 

 

Name of contact:

Dr Edward Bliss, Company Secretary

Telephone number of contact:

0207 388 7722

 

 

of


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRFMGGVFVRGZZM






DateSourceHeadlineCategory
17-May-13 07:00RNSInterim Management StatementResults and Trading Reports
16-May-13 13:20RNSHolding(s) in CompanyHolding(s) in Company
08-May-13 18:09RNSHolding(s) in CompanyHolding(s) in Company
08-May-13 17:47RNSHolding(s) in CompanyHolding(s) in Company
02-May-13 13:45RNSHolding(s) in CompanyHolding(s) in Company
01-May-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
30-Apr-13 07:00RNSFinal ResultsResults and Trading Reports
26-Apr-13 16:50RNSHolding(s) in CompanyHolding(s) in Company
24-Apr-13 15:47RNSHolding(s) in CompanyHolding(s) in Company
26-Mar-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
26-Mar-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
22-Mar-13 11:50RNSHolding(s) in CompanyHolding(s) in Company
20-Mar-13 13:15RNSHolding(s) in CompanyHolding(s) in Company
19-Mar-13 09:47RNSHolding(s) in CompanyHolding(s) in Company
15-Mar-13 12:01RNSTermination of Offer Period and Rule 10.8 WaiverCompany Announcement - General
26-Feb-13 17:35RNSHolding(s) in CompanyHolding(s) in Company
25-Feb-13 11:27RNSHolding(s) in CompanyHolding(s) in Company
22-Feb-13 14:41RNSHolding(s) in CompanyHolding(s) in Company
21-Feb-13 13:24PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plcMergers, Acquisitions and Disposals
21-Feb-13 10:56RNSHolding(s) in CompanyHolding(s) in Company
20-Feb-13 12:54PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plcMergers, Acquisitions and Disposals
19-Feb-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
19-Feb-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
15-Feb-13 10:39PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics Group plcMergers, Acquisitions and Disposals
12-Feb-13 12:25RNSHolding(s) in CompanyHolding(s) in Company
07-Feb-13 15:05RNSHolding(s) in CompanyHolding(s) in Company
07-Feb-13 13:41PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics GroupMergers, Acquisitions and Disposals
06-Feb-13 11:18PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics GroupMergers, Acquisitions and Disposals
06-Feb-13 11:02RNSForm 8 (OPD)Mergers, Acquisitions and Disposals
05-Feb-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.